ReviewThe Lancet. Global health2022
The public health playbook: ideas for challenging the corporate playbook.
Review in The Lancet. Global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
78 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Calorie (energy) labelling for changing selection and consumption of food or alcohol.The Cochrane database of systematic reviews · 2025Pooled it
- Understanding pharmaceutical industry coalitions: a case study of Mallinckrodt.Humanities & social sciences communications · 2026Article
- A narrative review of qualitative studies exploring the normalization of gambling for youth and younger adults.Health promotion international · 2026Review
- Turning the tables on industry narratives: a health communication playbook for promoting health.Health promotion international · 2026Article
- Commercial interests in health policy dialogues: a qualitative content analysis of NEDLAC's engagement with South Africa's Health Promotion Levy.Globalization and health · 2026Article
- The arms industry as a commercial determinant of health in the Middle East: a call for research.BMJ global health · 2026Review
- Why Prevention Needs More Than Individual Empowerment: Reclaiming Environmental Prevention.Journal of prevention (2022) · 2026Article
- Tobacco Industry Contributions to the Development of Ultraprocessed Food in the United States, 1985-2007: A Case Study of Lunchables.American journal of public health · 2026Article
- Are commercial determinants of health addressed in Australian health policies?Health promotion international · 2026Article
- Purdue's development of abuse-deterrent formulation opioids as a response to market competition: An industry documents analysis.SSM. Qualitative research in health · 2026Article
- The illusion of empowerment: commercializing women's health in the digital age.Health promotion international · 2026Article
- Commercial determinants of health-a scoping review of research 'made in Germany'.European journal of public health · 2026Article
- "They make it seem harmless": a qualitative investigation into women's perceptions about novel gambling promotions and public relations strategies.BMC public health · 2026Article
- Youth washing as a corporate social responsibility tactic of health-harming industries.Health promotion international · 2026Article
- Addressing Commercial Health determinants: Indigenous Empowerment and Voices for Equity (ACHIEVE)-protocol for a multiphase study.BMJ open · 2026Article
- Article
- Do ESG Frameworks Capture Corporate Health Impacts? An Analysis of the Food and Beverage Industry.International journal of environmental research and public health · 2025Article
- Navigating power in policy adoption: The political economy of noncommunicable diseases in Sierra Leone.SSM - health systems · 2025Article
- Public opinion on policy interventions for regulating four unhealthy commodity industries: a cross-sectional online survey of a representative sample of British adults 2023.BMC public health · 2025Article
- Do alcohol industry-funded organisations act to correct misinformation? A qualitative study of pregnancy and infant health content following independent analysis.Globalization and health · 2025Article
18 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Many commercial actors use a range of coordinated and sophisticated strategies to protect business interests-their corporate playbook-but many of these strategies come at the expense of public health. To counter this corporate playbook and advance health and wellbeing, public health actors need to develop, refine, and modernise their own set of strategies, to create a public health playbook. In this Viewpoint, we seek to consolidate thinking around how public health can counter and proactively minimise powerful commercial influences. We propose an initial eight strategies for this public health playbook: expand public health training and coalitions, increase public sector resources, link with and learn from social movements to foster collective solidarity, protect public health advocates from industry threats, develop and implement rigorous conflict of interest safeguards, monitor and expose corporate activities, debunk corporate arguments, and leverage diverse commercial interests. This set of strategies seeks to amplify inherent assets of the public health community and create opportunities to explicitly counter the corporate playbook. These strategies are not exhaustive, and our aim is to provoke further discussion on and exploration of this topic. TRANSLATION: For the Spanish translation of this paper see Supplementary Materials section.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.